BCWP A001Alternative Names: BCWP-A001
Latest Information Update: 09 Jul 2016
At a glance
- Originator BC World Pharm
- Class Antibacterials
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Bacterial infections
Most Recent Events
- 09 Jul 2016 Clinical trials in Bacterial infections in South Korea (PO)